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Abstract
Background: Chronic periodontal disease is an infectious disease consisting of prolonged inflammation of the
supporting tooth tissue and resulting in bone loss. Guided bone regeneration procedures have become common and
safe treatments in dentistry, and in this context dental stem cells would represent the ideal solution as autologous
cells. In this study, we verified the ability of dental pulp mesenchymal stem cells (DPSCs) and gingival mesenchymal
stem cells (GMSCs) harvested from periodontally affected teeth to produce new mineralized bone tissue in vitro, and
compared this to cells from healthy teeth.
Methods: To characterize DPSCs and GMSCs, we assessed colony-forming assay, immunophenotyping,
mesenchymal/stem cell phenotyping, stem gene profiling by means of flow cytometry, and quantitative
polymerase chain reaction (qPCR). The effects of proinflammatory cytokines on mesenchymal stem cell (MSC)
proliferation and differentiation potential were investigated. We also observed participation of several heat
shock proteins (HSPs) and actin-depolymerizing factors (ADFs) during osteogenic differentiation.
Results: DPSCs and GMSCs were successfully isolated both from periodontally affected dental tissue and controls.
Periodontally affected dental MSCs proliferated faster, and the inflamed environment did not affect MSC marker
expressions. The calcium deposition was higher in periodontally affected MSCs than in the control group.
Proinflammatory cytokines activate a cytoskeleton remodeling, interacting with HSPs including HSP90 and HSPA9,
thioredoxin-1, and ADFs such as as profilin-1, cofilin-1, and vinculin that probably mediate the increased acquisition in
the inflamed environment.
Conclusions: Our findings provide evidence that periodontally affected dental tissue (both pulp and gingiva) can be
used as a source of MSCs with intact stem cell properties. Moreover, we demonstrated that the osteogenic capability
of DPSCs and GMSCs in the test group was not only preserved but increased by the overexpression of several
proinflammatory cytokine-dependent chaperones and stress response proteins.
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Background
Chronic periodontal disease is an infectious disease
resulting in inflammation within the supporting tissue of
the tooth, with progressive attachment and bone loss. It
is characterized by pocket formation and/or gingival re-
cession [1]. Some 5% to 20% of any population suffers
from severe, generalized periodontitis; mild to moderate
periodontitis affects a majority of adults and represents
the main cause of tooth loss [2]. Along with dental car-
ies, periodontal disease is the main cause of tooth loss;
the teeth most commonly lost due to periodontal prob-
lems are the first and the second molars in the maxilla
[3]. As result of tooth loss, the alveolar process under-
goes bone resorption, causing a reduction of the amount
of available bone for the insertion of dental implants and
the achievement of prosthetic rehabilitation [4, 5].
Guided bone regeneration (GBR) procedures have
become a common and safe treatment in dentistry, and
autografts are considered the gold standard in GBR pro-
cedures for their osteogenic and osteoinductive proper-
ties. However, the principal limits are that a donor site is
required and only a limited amount of graft is often
recoverable [6–8]. For this reason, autologous mesen-
chymal stem cells (MSCs) would represent the ideal so-
lution for stem cell-based bone tissue engineering.
Tissue engineering (TE) and regenerative medicine
(RM) are emerging fields, focused on the development
of alternative strategies for tissue or organ repair, that
have made significant progress in the last years [9, 10].
TE provides new regenerated tissues by the appliance of
cells, scaffold, and growth factors, alone or in combin-
ation; nowadays RM has made exceptional progress
leading to the regeneration of numerous organs and
organ systems by using the capability of stem cells to
differentiate into specialized cell types [11–13].
In adult humans stem cells are hosted in niches, a
microenvironment that includes cellular and noncellular
components that interact with each other to control the
adult stem cells delegated to maintain the integrity of
the tissues [14]. MSCs, defined as a population of non-
hematopoietic fibroblast-like cells, able to differentiate
into multiple lineages, including osteoblasts, adipocytes,
and chondrocytes [9, 15]. During aging, the number of
stem cell niches decreases, limiting the possibility of rec-
ognizing new sites for the collection of samples and
obtaining multiple lines of differentiation for tissue en-
gineering [14, 16, 17].
Over the last years, many niches have been described
in the oral cavity: the dental pulp from permanent or de-
ciduous teeth, the periodontal ligament, the apical pa-
pilla, the dental follicle, and the gingival tissue [18–22].
Recently, oral MSCs have also been harvested from
dental tissue that is not healthy, such as fractured teeth
and teeth affected by caries or irreversible pulpitis or
aggressive periodontitis [23–26]. Dental pulp MSCs
(DPSCs) and gingival MSCs (GMSCs) are clonogenic
cells capable of both self-renewal and multiple lines of
differentiation; moreover, compared to the bone marrow
MSCs (BM-MSCs), DPSCs and GMSCs demonstrate the
ability to proliferate faster, to be mostly homogenous,
and to have excellent capacity to differentiate into osteo-
genic cells [18, 27–29]. It is controversial, however,
whether proinflammatory cytokines could compromise
multipotency and regenerative potential in several types
of MSCs in vitro. There is growing evidence that proin-
flammatory cytokines such as interleukin (IL)-1β or
tumor necrosis factor (TNF)-α are important causal fac-
tors of cellular proliferation and differentiation in human
MSCs [26, 30–33]. Recently, some studies have focused
on a possible link between proinflammatory cytokines,
bone formation, and various heat shock proteins (HSPs).
Inflammation and hypoxic conditions induce the expres-
sion of several HSPs engaged in protein folding and actin
cytoskeletal organization [34–36]. The actin polymerization
remodeling is a fundamental process during lineage-specific
differentiation; in this context, Chen et al. showed
that the inhibition of main actin depolymerizing fac-
tors (ADFs) enhance osteoblastic differentiation in
human stromal stem cells [36].
In this study, we evaluated the inflammatory effects on
human dental stem cells, particularly DPSCs and
GMSCs from inflamed dental tissue, and we investigated
if they can be used both as an MSC source and as host
tissue in regenerative therapies. We compared the MSC
markers, MSC gene profile, proliferation, and in vitro
differentiation ability of the DPSCs and GMSCs har-
vested from periodontally compromised teeth compared
to healthy teeth. We investigated if the proinflammatory
microenvironment negatively affects dental MSC charac-
teristics and properties, and we speculated about a closer
link between chronic inflammation and bone formation
through the involvement of several HSPs and ADFs.
Methods
Dental pulp and gingival tissue extraction
Dental pulp was extracted from the teeth of healthy
adults aged 18–75 years. The eligibility criteria for par-
ticipants were as follows: extraction needed for molars
suffering from severe periodontal disease (mobility grade
III; the test group), extraction needed for wisdom teeth
for orthodontic reasons (the control group), no suspect
or visibly pregnancy in females, and a positive response
to the vitality test performed on teeth to be extracted.
Before the extraction, each patient had to rinse the
mouth with 0.2% chlorhexidin for 1 min (Meridol®, Gaba
Vebas S.r.l., Rome, Italy) to decontaminate the oral cav-
ity. Gingival tissue was collected while the patient under-
went oral surgery procedures for tooth extraction.
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Establishment of dental pulp and gingival cell cultures
After surgery, the pulpal or the gingival tissue was trans-
ferred in StemLine Mesenchymal Stem Cell Expansion
Medium (Sigma-Aldrich, Milano, Italy) enriched with
0.2 mg/ml gentamicin, 0.25 mg/ml levofluoxacin,
0.10 mg/ml vancomicin, and 0.25 mg/ml fluconazole in
a 50-ml tube, and within 24 h the samples were digested.
The digestion was carried out in a solution of 5 mg/ml
collagenase G (Abiel srl, Palermo, Italy) and 2 mg/ml
collagenase H (Abiel srl, Palermo, Italy) in a 4:1 ratio for
4 h at 37 °C under agitation. The digests containing pri-
mary cells from the pulp or the gingiva were centrifuged
and transferred to a T25 cell culture flask (EuroClone
spa, Milano, Italy) or a p60 dish culture (referred to as
passage (P)0). The cells were kept in culture in StemLine
Mesenchymal Stem Cell Expansion Medium enriched
with 0.5 μg/ml gentamicin, 0.25 μg/ml levofluoxacin,
0.10 μg/ml vancomicin, 0.25 μg/ml fluconazole, and 5%
fetal bovine serum (FBS) and incubated at 37 °C in 5%
CO2. Primary cells attached to the flask in 4–5 days;
once they reached 80% confluence (in about 2 week)
they were trypsinized and subculture was started (P1).
By subculture P4, the antibiotic and antifungal cover
was abolished (expansion medium). P1 to P8 cells were
used for the in vitro assays.
Colony-forming assay
A single-cell suspension (P0) of DPSCs and GMSCs
from both the periodontally affected and healthy donors
were seeded in a six-well culture in StemLine Mesenchy-
mal Stem Cell Expansion Medium with 10% FBS at a
density of 300 cells/well and cultured at 37 °C in 5%
CO2. After 14 days, the cells were fixed in 4% parafor-
maldehyde and stained with 0.1% crystal violet. Only the
cellular groups containing more than 50 cells were
considered as colonies.
Population doubling, cell proliferation curve, and cytokine
cytotoxicity
Proliferation was assayed by trypan blue (Sigma-Aldrich)
according to the manufacturer’s instructions. The P2
GMSCs or P2 DPSCs from periodontally affected or
healthy donors were seeded at a density of 4 × 103 cells/
cm2. The P4 healthy (H)-DPSCs or P4 H-GMSCs with
or without 20 ng/ml IL-1β and 40 ng/ml TNF-α were
seeded in a 96-well plate at a density of 4 × 1103 cells/
cm2 and cultured up to 120 h. The cell counts were per-
formed by optical microscope observation after trypan
blue staining every 24 h during the incubation period.
The doubling time (DT) was calculated accordingly to
literature data (http://www.doubling-time.com/compu-
te.php). Three sets of experiments for each sample were
used for calculations.
Cytokine toxicity assay
The P4 H-GDPSCs or P4 H-DGMSCs with or without
20 ng/ml IL-1β and 40 ng/ml TFN-α were seeded in a
96-well plate at a density of 4 × 1103 cells/cm2 and cul-
tured up to 72 h. The cell viability was evaluated by UV
absorption at 550 nm at 24, 48, and 72 h using a micro-
plate reader, after 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) incubation for 4 h at
37 °C. P5 BM-MSCs (Lonza, Walkersville, MD, USA)
were used as the positive control.
Flow cytometric analyses
Cell cycle cytofluorimetric analysis
Single-cell suspensions of periodontally affected (P)-
DPSCs, H-DPSCs, P-GMSCs, and H-GMSCs (P4 culture
passages) were obtained and DNA content analysis was
performed according to Nicoletti’s protocol. Briefly, 1 ×
106 cells were fixed in 70% ethanol, rehydrated in
phosphate-buffered saline (PBS), and then resuspended
in a DNA extraction buffer (with 0.2 M NaHPO4 and
0.1% Tritonx-100 at pH 7.8). After staining with 1 μg/mL
propidium iodide for 5 min, fluorescence intensity was de-
termined by analysis on a FACS Calibur flow cytometer
(Becton-Dickinson, New Jersey, USA). Data acquisition
was performed with CellQuest (Becton Dickinson) soft-
ware, and the percentages of G1, S, and G2 phase cells
were calculated with the MODFIT-LT software program
(Verity Software House, Inc.). The proliferation index (PI)
was expressed as % G2 + % M.
Surface marker cytofluorimetric analysis
The P-DPSCs, H-DPSCs, P-GMSCs, and H-GMSCs (P4
culture passages) were harvested and filtered through a
40-μm filter mesh and suspended at a concentration of
1 × 1106 cells/ml. Then 100 μl of cell suspension contain-
ing 5 × 105 cells was used for each flow cytometric test.
Immunophenotyping in flow cytometry
Human anti-HLA-DR, human anti-CD34, and human
anti-CD45 monoclonal antibodies were tested on P4 P-
DPSCs, H-DPSCs, P-GMSCs, and H-GMSCs, and were
detected with the appropriate secondary antibody (Table 1).
The incubation conditions were in accord with the manu-
facturer’s instructions. Unstained cells were used as the
negative control. P4 BM-MSCs used as the positive control
are not shown.
Stem cell phenotypes
The cells were tested for expression of the MSC surface
markers Stro-1, CD146, CD29, and SSEA4, with the ap-
propriate human anti-monoclonal antibody (Table 1).
The antibody dilution, incubation, and detection condi-
tions are also shown in Table 1.
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All reaction mixtures were then acquired with a FACS
Calibur flow cytometer (Becton-Dickinson, New Jersey,
USA) and analyzed with the CellQuest Pro software.
The specific isotype control antibodies were used as the
negative control.
Isolation of total RNA and polymerase chain reaction
Total RNA was extracted and purified using the
E.Z.N.A. Total RNA Kit I (Omega Bio-Tek Inc., GA,
USA) according to the manufacturer’s instructions. RNA
quantity and quality were assessed by Nano Drop 2000
(Thermo Scientific); 2 μg limbal fibroblast-like stem cell
(f-LSC) total RNA was reverse-transcribed to cDNA in a
volume of 20 μl with Oligo dT primers (Applied Biosys-
tems, CA, USA) and the Reverse Transcriptase Rnase kit
(Improm II, Promega, WI, USA). Real-time quantitative
polymerase chain reaction (qPCR) analyses were per-
formed to analyze IL-1β receptor (IL-1β-R1) and TNF-α
receptor (TNF-R1) expression, the cell proliferation, the
stem gene profile, and the osteogenic differentiation, and
to detect the expression of the ADFs and HSPs. All reac-
tions were performed using the Quantitect SYBR Green
PCR Kit (Qiagen, CA, USA) on the RotorGene Q Instru-
ment (Qiagen). Each cDNA sample was mixed with spe-
cific primer sets (listed in Table 2) and PCR master mix.
The qPCR reactions were performed using the following
parameters for 45 cycles: denaturation at 95 °C for
3 min, 95 °C for 20 s, annealing at 60 °C for 30 s, and
elongation at 72 °C for 60 s. Reactions were performed
at least in triplicate. The specificity of the amplified
products was determined by melting peak analysis. The
relative quantification model with efficiency correction
was applied to normalize the expression of the target
gene to β-actin (used as the housekeeping gene) and to
compare gene expression with BM-MSCs (used as a
positive cell control) using the Delta Delta Ct method
validated according to the guidelines of Livak and
Schmittgen [37]. The results were represented as histo-
grams on GraphPad Software by setting the gene expres-
sion of the positive control equal to 1. The MSCs were
used at P5.
The protein-interaction networks (PIN)
Network analysis was performed on the ADFs, HSPs,
and osteogenic proteins using the STRING (Search Tool
for the Retrieval of Interacting Genes/Proteins) website
(http://string-db.org/). The co-mentions, co-expression
and associations in curated databeses were set as the evi-
dence for functional links.
In vitro bone formation
P-DPSCs, H-DPSCs plus cytokines, H-DPSCs, P-GMSCs,
H-GMSCs plus cytokines, and H-GMSCs (all 5 × 103/
cm2) were cultured in home-made osteogenic differenti-
ation medium (ODM); 5 × 103/cm2 H-DPSCs and H-
GMSCs were cytokine preconditioned. In detail, H-DPSCs
plus cytokines and H-GMSCs plus cytokines were incu-
bated up to 72 h in expansion medium with 20 ng/ml IL-
1β and 40 ng/ml TNF-α and cultured in ODM. After
21 days of culture in the ODM, cells were stained with
Alizarin Red S (Sigma-Aldrich, St. Louis, USA) to detect
the calcium deposits. Briefly, the medium was removed
and the cells were fixed with 4% formaldehyde solution
for 30 min and, after fixation, rinsed twice with distilled
water and stained with 2% Alizarin Red S (pH 4.2) for
3 min. After observation under a light optical microscope
the images were acquired with a Nikon DS-fi1. The
quantification of the calcium deposits was assessed by
measurement of the optical density (OD) at 550 nm.
ODM consisted of Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 15% FBS, 10–4 mM dexa-
methasone (Sigma-Aldrich), 10 mM glycerophosphate
Table 1 Human antimonoclonal antibodies used in flow cytometry analysis for detection of mesenchymal stem cell markers
Antibody, localization marker Code number Dilution Incubation
Primary antibodies
Stro-1, surface Thermo Fisher Sc, 39-8401 1:100 o/n, r.t.
CD146, surface Milteny Biotec, 130-092-851 1:50 30 min, r.t
CD29, surface Milteny Biotec, 130-101-258 1:50 30 min, r.t.
SSEA4, surface Milteny Biotec, 130-98-371 1:100 30 min, r.t.
CD34, surface Santa Cruz, sc-19621 1:50 o/n , r.t.
CD45, surface Santa Cruz, sc-28369 1:50 o/n , r.t.
HLA-DR, surface Santa Cruz , sc-18875 1:50 o/n , r.t.
Secondary antibody
AlexaFluor 488 Life Technologies, Z25402 1:50 20 min, r.t.
AlexaFluor 594 Life Technologies, Z25007 1:50 20 min, r.t.
o/n overnight, r.t. room temperature
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(Sigma-Aldrich), and 0.05 mM ascorbic acid (Sigma-
Aldrich) [9]. P6 MSCs were used for in vitro bone
formation assay.
Statistical analysis
All assays were performed in triplicate. The data are re-
ported as means ± SD and compared using the appropri-
ate version of the Student’s unpaired t test or one-way
analysis of variance and post Tukey’s multiple compari-
son test. p < 0.05 was considered statistically significant.
Results
Inflamed dental tissue-derived MSCs show a higher
proliferative ability
DPSCs and GMSCs were isolated from 49 patients. The
subjects were divided into two major groups: 1) the
periodontally affected group (P, the test group; n = 37);
and 2) the healthy group (H, the control group; n = 12).
For each patient, pulpal and gingival tissues were ex-
tracted. Nine of the total samples (n = 5 test group; n = 4
control group) were unsuccessfully processed with high
grades of bacterial contamination. For all 40 remaining
samples, a cell suspension was generated after enzymatic
digestion. The first plastic adherent cells were detected
from all cultures between 7 and 10 days after prepar-
ation, and primary cells from healthy tissue initially grew
much faster than those from periodontally affected tis-
sue. The cultures (P0) appeared heterogeneous in shape
and size, and the cells showed the ability to grow out
from tissue now totally digested and to form clone-like
growth (Fig. 1a). Generally, as culture progressed, gin-
gival cells reached confluence at day 15 (12–18 days)
Table 2 The primer sequence list used for the amplification of mesenchymal stem cell cDNA
Gene Primer sequence Code number
ABCG2 QT00073206
CD105 QT0001335
THY-1 QT00023569
CD73 QT00027279
NANOG QT01844808
OCT4 QT00210840
SOX2 F:5'- GGAGACGGAGCTGAAGCCGC-3'
R:5'GACGCGGTCCGGGCTTGTTTT-3'
MWG
IL-1β-R1 F:5'-CCAGGGAACTATTTTTATTTTCTGG-3'
F:5'-CTGAGAAGCTGGACCCCTTG-3'
MWG
TNF-R1 F:5'-GGGATAAAAGGCAAAGACCAA-3'
F:5'-TCCTTCACCGCTTCAGAAAA-3'
MWG
ccnd1 QT00495285
cdkn1b QT00998445
c-myc F:5'-AAACACAAACTTGAACAGCTAC-3'
F:5'-ATTTGAGGCAGTTTACATTATGG-3'
MWG
runx-2 F:5'-TACGACTGGACGCTGGTGC-3'
R:5'-TTCATGGGTCGCTTGACGT-3'
MWG
opn F:5'-TGTGGGTTTCAGCACTCTGGTCA-3', R:5'-AAGCGAGTTGAATGGTGC-3' MWG
ocn F:5'-CTGACCTCACAGATGCCAAG-3'
R:5'-GTAGCGCCGGAGTCTGTTC -3'
CFL-1 (cofilin) F:5'-TGCGGCTCCTACTAAACGG-3'
F:5'-ACGCACCTTCATGTCGTTGA-3'
MWG
PFN-1 (profilin) F:5'-ACCCGGAAACAAGAAGAC-3'
F:5'-ACTGGTCCGATAACCTCCCA-3'
MWG
VCL (vinculin) F:5'-ATGTCTCCTATATCCTGGTTT-3'
F:5'-GCAGGAAGTGTCCTTCAGAC-3'
MWG
HSPA9 (mortalin) F:5'-TACAGCAGATGGTGAGCGAC-3'
R:5'-TGCTGTGTGCCCCAAGTAAT-3'
MWG
TXN-1 (thioredoxin-1) F:5'- GTGAAGTCAAATGCACGCCA-3'
R:5'-GCAGATGGCAACTGGTTATGT-3'
MWG
HSP90AA1 F:5'-GTGAAGTCAAATGCACGCCA-3'
R:5'-GCAGATGGCAACTGGTTATGT-3'
MWG
F forward, R reverse
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and pulpal cells at day 20 (14–26). All the primary cells
showed a typical fibroblast-like morphology, and they
were homogeneous in shape and size (Fig. 1a). The
CFU-F assay is the most frequently used test to analyze
the clonogenic potential of isolated MSCs and to dem-
onstrate MSC enrichment. Thus, we performed a CFU-F
assay on all dental MSCs; P-DPSCs, H-DPSCs, P-
GMSCs, and H-GMSCs displayed the highest time-
dependent colony-forming ability, and a significant
enrichment was observed in periodontally affected den-
tal MSCs with respect to their healthy controls. Based
on counting, the number of colonies per 300 seeded
cells was 90.4 ± 18.07 and 140.2 ± 15.8 (p < 0.05) for the
P-DPSCs at 7 and 14 days, respectively, and 88.3 ± 12.03
and 146.8 ± 28.8 (p < 0.05) for the P-GMSCs at 7 and
14 days, respectively; the results were 75.1 ± 15.05 and
121.2 ± 23.6 (p < 0.05) for the H-DPSCs at 7 and 14 days,
respectively, and 70.3 ± 28.03 and 111.03 ± 24.8 (p < 0.05)
for the H-GMSCs at 7 and 14 days, respectively (Fig. 1b).
After they reached confluence, the cells were harvested
and subcultured. From culture P1, a modest change in
growth behavior was observed; in spite of the MTT assay
Fig. 1 Colony-forming unit assays and monolayer subculture. a Representative images of pulpal (DPSCs) and gingival (GMSCs) mesenchymal stem cell
colonies (P0) and monolayer subcultures (P1), isolated from periodontally affected (P) and healthy (H) patients and stained with crystal violet. b Colony-
forming assay (CFU-F) in dental mesenchymal stem cells. c Cell growth curve of P-DPSCs and H-DPSCs by trypan blue viability assay (P2). d, e The
typical fibroblast-like cell shape of a monolayer subculture of P-DPSCs and H-DPSCs. f The bar plot represents the comparative cell cycle distribution
analysis between P-DPSCs and H-DPSC (G2M+ S = proliferation index (PI)). g Cell growth curve of P-GMSCs and H-GMSCs by trypan blue viability assay.
h, i The typical fibroblast-like cell shape of a monolayer subculture of P-GMSCs and H-GMSCs at 72 h. l The bar plot represents the comparative cell cycle
distribution analysis between P-GMSCs and H-GMSC (G2M+ S = PI). Cell cycle analysis at P4. *p < 0.05. n.s. not significant
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revealing no significant difference (p > 0.05) in the
growth rate (Additional file 1), the P-DPSCs and P-
GMSCs proliferated faster than healthy control cells. DT
was established at 28.83 ± 2 h vs. 34.37 ± 5 h for P-
DPSCs vs. H-DPSCs, respectively, and at 26.22 ± 8 h vs.
29.13 ± 4 h for P-GMSCs vs. H-GMSCs, respectively
(Fig. 1c and g; Additional file 1). The cell cycle analysis
assigned a proliferation index (PI) G2M+ S of 9.90 ± 3.1%
vs. 5.23 ± 2.3%, respectively, in P-DPSCs vs. H-DPSCs and
a PI of 23.85 ± 4.1% vs. 12.72 ± 3.24%, respectively, in P-
GMSCs vs. H-GMSCs (Fig. 1f and l; Additional file 1).
The difference in PI between P-DPSCs and H-DPSCs and
between P-GMSCs and H-GMSCs was statistically signifi-
cant (p < 0.005).
Human healthy and periodontally affected gingival and
pulpal dental cells express putative mesenchymal stem
cell markers, are negative for hematopoietic
differentiation clusters, and represent a stem gene profile
The isolated cells did not display any hematopoietic
surface markers (CD34 and CD45) and HLA-DR. Some
increases were detected in the expression levels of CD34
in periodontally affected samples; however, this was not
statistically significant (p > 0.005) (Fig. 2). The expression
of putative the mesenchymal surface stem cells markers
Stro-1, CD146, CD29, and SSEA4 was observed by flow
cytometry and compared to BM-MSCs (data not shown)
(Fig. 3). A higher Stro-1+/CD146+/SSEA-4+ cell popula-
tion (p < 0.05) in P-DPSCs and P-GMSCs with respect to
their healthy controls was detected. In all samples, CD29
stayed highly positive (about 100%). The expression
values are reported in Additional file 2.
We compared the stem cell molecular expression
pattern in the P-DPSCs, P-GMSCs, H-DPSCs, and H-
GMSCs as differences in fold change. Generally, we
found a higher expression of all stem markers in dental
mesenchymal stem cells with respect to the BM-MSCs
(used as positive control; value of relative gene expres-
sion = 1). In detail, the mRNA levels of the embryonic
stem cell markers NANOG and OCT4 showed very high
fold change with respect to BM-MSCs. Moreover, the
expression levels of the main stemness genes were sig-
nificant higher in periodontally affected MSCs compared
to their healthy controls whereas, a lower mRNA level
Fig. 2 Immunophenotype flow cytometric assay. a Each field shows a representative sample. Cells are negative for CD34, CD45, and HLA-DR. The
green peak shows the positive cells; the purple peak shows the isotype controls. The increases in CD34 in periodontally affected samples were not
statistically significant. (Control: isotype controls were anti-IgM for Stro-1 and anti-IgG1 for SSEA4, CD146, and CD29.) b Scatter dot plots represent
the expression levels of the immunophenotype cell markers (culture passage P5). DPSC dental pulp mesenchymal stem cell, GMSC gingival
mesenchymal stem cell, H healthy donor, P periodontally affected donor
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of the CD73 surface marker was found in periodon-
tally affected MSCs compared to their healthy control
(p<0.05; Fig. 4).
The proinflammatory cytokine cocktail facilitates pulpal
and gingival mesenchymal stem cell expansion in vitro
We investigated the effect of the proinflammatory cyto-
kines IL-1β and TNF-α. Firstly, we confirmed the
presence of IL-1β and TNF-α receptors in P-GMSCs
and P-DPSCs and their healthy controls, in basal and
under cytokine treatment conditions (Additional file 3).
After 72 h of treatment no cytotoxic effect on cells was
found; we even found a proliferation advantage acquisi-
tion. Indeed, a decrease in DT was detected in H-
DPSCs and H-GMSCs treated with IL-1β and TNF-α,
mimicking the P-DPSC and P-GMSC proliferation
curve (Fig. 5a), and the MTT analysis showed an
increase in the percentage of vital cells (Fig. 5b). We
evaluated the principal molecules involved in cell pro-
liferation. The qPCR analysis for c-myc (myc-protonco-
gene), ccnd1 (cyclin-D1), and cdkn1b (cyclin-dependent
kinase inhibitor 1B) was assessed for each time point of
culture in H-DPSCs and H-GMSCs treated with IL-1β
and TNF-α versus untreated healthy controls. In line
with the MTT results we found a significant upregula-
tion of c-myc and ccnd1 in dental MSCs (Fig. 5c, mid-
dle and lower panels). Consistent with the above
results, we found a downregulation of the ccnd1 inhibi-
tor (cdkn1b). In addition, as a consequence of the
cytokine treatment, the same genes were found to be
modulated with the opposite trend in BM-MSCs (in
Fig. 5c, upper panel).
Fig. 3 Stem cell phenotyping by flow cytometry. a A representative figure of the cytometry analysis in periodontally affected (P) pulpal (DPSC) or
gingival (GMSC) mesenchymal stem cells (P-DPSCs and P-GMSCs, respectively) and their healthy controls (H-DPSCs and H-GMSCs). In the same
histogram graph, the green peak shows the positive cells and the purple peak is the unstained cells used as negative control. (Control: Iisotype
controls were anti-IgG1 for CD34 and CD45, and anti-IgG2 for HLA-DR.) b Scatter dot plot graphs represent expression levels of the mesenchymal
stem cell markers Stro-1, CD146, CD29, and SSEA4 (culture passage P5)
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Inflammation and stem cell gene profile correlation
To investigate whether the inflammation environment af-
fects stem cell gene profile, a qPCR analysis was performed
to compare H-GMSCs and H-DPSCs after 20 ng/ml IL-1β
and 40 ng/ml TNF-α up to 72 h versus untreated H-
GMSCs and H-DPSCs. In Fig. 5d the histograms represent
the mRNA levels expressed as fold change. In cytokine-
treated H-GMSCs and H-DPSCs all MSC markers showed
an increase with respect to H-GMSCs and H-DPSCs (p <
0.05), except for CD105 in H-DPSCs after the treatment
(p> 0.05) and CD73 which showed a decrease (p < 0.05).
We found increases of about 1.06- and 1.07-fold in
ABCG2 (p < 0.05), 1.06 = and 1.37-fold in CD105 (p > 0.05
and p < 0.05), 1.08- and 1.33-fold in THY-1 (p < 0.05),
1.15- and 1.76-fold in NANOG (p < 0.05), 1.77- and 1.14-
fold in OCT4 (p < 0.05), and 2.89- and 1.83-fold in SOX-2
(p < 0.05) in H-DPSCs plus cytokines vs H-DPSCs and H-
GMSCs plus cytokines vs H-DPSCs, respectively.
In vitro bone formation: inflammation, cytoskeleton
modulation, and osteogenesis
To evaluate the effect of the inflammatory conditions on
the osteogenic differentiation potential in vitro, H-
DPSCs and H-GMSCs were treated with IL-1β and
TNF-α up to 72 h and then they were cultivated in
ODM. After 15 days of the differentiation culture pro-
cedure, phenotypic and gene analyses were performed to
compare treated healthy cells and periodontally affected
cells with untreated healthy dental MSCs. Using phase-
contrast microscopy the Alizarin Red S staining was
evaluated, and we observed that treated MSCs and peri-
odontally affected MSCs appeared more stained than
untreated healthy controls (Fig. 6a). Confirming these
observations, the Alizarin Red S absorbance was mea-
sured at 550 nm (Fig. 6b). We found a relative OD
increase of about 1.05 and 1.31 in treated H-DPSCs and
P-DPSCs, and of about 1.41 and 1.67 in treated H-
GMSCs and P-GMSCs compared to their healthy con-
trols. Moreover, the early osteogenic marker runx-2 was
found to be upregulated by 1.41-fold and 1.38-fold,
respectively, in P-DPSCs and P-GMSCs (p < 0.05)
compared to their healthy controls; the difference be-
tween treated and untreated MSCs was not significant
(p > 0.05). However, treated MSCs and periodontally af-
fected MSCs showed significantly higher mRNA levels
of the later osteogenic differentiation markers compared
to their untreated healthy controls. Specifically, we de-
tected an upregulation in osteopontin levels of 2.09-fold
and 2.18-fold in treated H-DPSCs and P-DPSCs and
1.42-fold and 1.71-fold in treated H-GMSCs and P-
GMSCs (p < 0.05), and upregulation of osteocalcin levels
of 1.14-fold and 1.15-fold in treated H-DPSCs and P-
DPSCs and 1.25-fold and 1.27-fold in treated H-GMSCs
and P-GMSCs (p < 0.05) (Fig. 6b).
IL-1β and TNF-α increase the expression of several ADFs
and HSPs
A computational STRING analysis was performed to in-
vestigate the functional interaction between osteogenic
differentiation, actin cytoskeletal organization, and cyto-
kine response. The chief members of each protein cluster
analyzed were the following: runx-2, opn, ocn (osteogenic
differentiation markers), cofilin-1 and profiling-1 (ADFs),
vinculin (the key depolymerization factor), and hsp90,
hspA9, and txn-1 (the main heat shock proteins). Based
on the criteria set, we obtained a network of protein-
protein interactions (PPI) that linked together all three
protein clusters (Fig. 7a). After 15 days of osteoblastic dif-
ferentiation, qPCR analysis was assessed to test the mRNA
levels of ADFs and HSPs. Generally, the cytokine-treated
Fig. 4 Stem cell gene expression profile of dental periodontally affected (P) and healthy (H) mesenchymal stem cells (MSCs) from dental pulp (D)
and gingival (G) tissues. a Comparative analysis of surface marker expression in P-DPSCs, H-DPSCs, P-GMSCs, and H-GMSCs. b Comparative analysis
of nuclear surface marker expression in P-DPSCs, H-DPSCs, P-GMSCs, and H-GMSCs. Mean values ± SD of all samples studied are reported. Actin β
was used as the housekeeping gene. mRNA expression of all analyzed genes was normalized against BM-MSCs (positive control, relative gene
expression value = 1). Culture passage P5. *p < 0.05; Ntera is used as internal control. FC fold change
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Fig. 5 Two cytokines promote H-GMSC and H-DPSC expansion. a Cell growth curve of healthy dental pulp mesenchymal stem cells (H-DPSCs) and
healthy gingival MSCs (H-GMSCs) with and without cytokines (cyt; 20 ng/ml interleukin-1beta (IL1β) and 40 ng/ml tumor necrosis factor alpha (TNFα)
for 72 h) by trypan blue viability assay. b Cytotoxicity assay: H-DPSCs and H-GMSCs without and after cytokine treatment. c qPCR analysis of cell cycle
regulators and proliferation markers ccnd1, cdnk1b, and c-myc in H-DPSCs + cyt and H-GMSCs + cyt and their healthy controls at 24, 48, and 72 h.
d Comparative analysis of nuclear and surface marker expression in H-DPSCs + cyt and H-GMSCs + cyt and their healthy controls at 72 h. Bone marrow
MSCs (BM-MSCs) used as positive control (relative gene expression value = 1); β-actin is the housekeeping gene. Mean values ± SD of all samples
studied are reported. SD bars are based on three independent experiments. Culture passage P5. *p < 0.05. FC fold change, n.s. not significant
Fig. 6 The osteogenic potential of pulpal (DMSCs) and gingival (GMSCs) mesenchymal stem cells. a A representative image of Alizarin Red assay stained
calcium deposits after 15 days of osteogenic differentiation cultured in healthy (H)-DPSCs and H-GMSCs with or without cytokine (cyt) preconditioning,
and periodontally affected (P)-DPSCs, P-GMSCs, and bone marrow MSCs (BM-MSCs) with or without cytokine preconditioning (control). b The bar graph
represents the quantitative analysis of Alizarin by means of spectrometry (reading at 550 OD). c the bar graphs represent the relative mRNA expression
of early and later osteogenic differentiation markers. Culture passage P5. *p < 0.05; **p < 0.01. FC fold change, n.s. not significant
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and periodontally affected MSCs expressed lower mRNA
levels of ADFs and higher mRNA levels of HSPs. Specific-
ally, ADF downregulation and vinculin upregulation were
found in cytokine-treated and periodontally affected
MSCs (p < 0.05) with respect to untreated healthy controls
(Fig. 7b). Moreover, upper levels of about 2.5- and 5-fold
were found in hsp90, hspA9, and txn-1 expression in
cytokine-treated and periodontally affected MSCs com-
pared to untreated healthy controls (Fig. 7c).
Discussion
For decades, extraordinary interest has emerged in the
field of MSCs because of their differentiation potential
that introduces them for possible use in TE, RM, and
cell and gene therapy for clinical applications. Scientists
are ongoing in their search for the best source of MSC
tissue. The current elective tissues to this end are bone
marrow and adipose tissue, although the isolation of
these MSCs is an invasive procedure for both patients
and donors. In view of this, the possibility to isolate
MSCs from discarded tissue is a fascinating idea and
MSCs from periodontally affected patients could be a
good alternative. Even though it has been shown in the
literature that proinflammatory cytokines affect the
MSC properties, the effects of inflammation due to peri-
odontitis and its effects on the features of dental MSCs
remain unclear [26, 30, 31].
In the present study, we confirmed the presence of
MSCs in human dental pulp and gingival tissue har-
vested from periodontally affected patients and for the
first time, to best of our knowledge, we compared their
stem features to DPSCs and GMSCs harvested from
Fig. 7 IL-1β and TNF-α increase the expression of several ADFs and HSPs. a The interaction between cytoskeleton-regulating proteins, anti-
inflammatory chaperone proteins, and the osteogenic specific markers performed at http://string-db.org/. b, c The bar graphs represent the qPCR
analysis for b ADF gene and c heat shock protein gene in bone marrow mesenchymal stem cells (BM-MSCs), BM-MSCs + cytokines (cyt; 20 ng/ml
IL1β + 40 ng/ml TNFα), healthy (H) dental pulp MSCs (DPSCs), H-DPSCs + cyt, periodontally affected (P)-DPSCs, healthy gingival MSCs (H-GMSCs), H-
GMSCs + cyt, and P-GMSCs. Mean values ± SD of all samples studied are reported. SD bars are based on three independent experiments. Culture
passage P6. *p < 0.05. FC fold change, n.s. not significant
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healthy donors at the same time. The cells isolated from
all groups showed a typical fibroblast-like shape and
displayed positivity for the principle stem markers Stro-
1, CD46, CD29, and SSEA4, and they did not display
surface expression for any hematopoietic marker (CD34
and CD45). Our results suggested that the inflamed
condition relating to the periodontal status of the pa-
tients had no effect on dental MSC viability, whereas it
could improve the growth ability and stem cell gene
profile of DPSCs and GMSCs. This view was supported
by proinflammatory cytokine preconditioning experi-
ments that demonstrated that H-DPSCs and H-GMSCs
are able to mimic P-DPSCs and P-GMSCs, displaying
similar proliferation curves and gene expressions when
treated with IL-1β and TNF-α [31, 32]. Specifically, P-
DPSCs and P-GMSCs showed a clear, higher expression
of the cardinal stem nuclear markers NANOG, OCT4,
and SOX-2, and stem superficial markers ABCG2,
CD105, and THY-1, compared to healthy controls and
the internal positive control (BM-MSCs). Moreover,
our data on H-DPSCs and H-GMSCs under proinflam-
matory conditions in vitro showed that osteoblastic dif-
ferentiation capacity is not only well preserved but also
is significantly higher than under nonstimulated condi-
tions, and almost equal to periodontally affected MSCs.
This evidence was confirmed by a higher calcified
extracellular matrix formation and a higher expression
of early and later osteogenic differentiation markers
(runx2, osteopontin, and osteocalcin) in the cytokine-
treated H-DPSCs and H-GMSCs as well as in the peri-
odontally affected MSCs [38–40].
It has already been shown that, in inflammatory
environments, several mediators activate a set of biological
process such as cell survival, proliferation, and cell differen-
tiation in MSCs [41–46]. During lineage-specific differenti-
ation, human stromal stem cells exhibit significant changes
in morphology. The differentiation process is closely linked
to the remodeling of the actin cytoskeletal organization by
means of the collaboration between the actin depolymeriz-
ing factors and chaperone proteins [47–51]. In the first in-
stance, the ADFs bind to actin monomers and filaments,
causing depolymerization of actin filaments preventing
their reassembly and hindering differentiation [52–55]. In
the second instance, chaperone/HSP proteins, including
hsp90, hspA9, and thioredoxin, assist the main ADFs (cofi-
lin, profiling, and vinculin) to model actin polymerization
status [33–36, 56, 57].
Our in vitro data suggested that the chronically inflamed
environment, perpetuated by persistent proinflammatory
cytokines, could be an advantage for the human P-DPSCs
and P-GMSCs. This inflammatory background maintains
high expression levels of hsp90, txn-1, and hspA9 that fi-
nally allows the stabilization of actin filaments by means
vinculin, profilin-1, and cofilin-1.
Conclusions
Our results confirm that the chronic inflammatory
microenvironment that exists in periodontitis does not
negatively affect the number or the stem cell marker
profile of P-DPSCs and P-GMSCs. The proinflammatory
cytokines permit a higher osteogenic differentiation po-
tential, controlling MSC fate through several regulatory
mechanisms involving remodeling of the cytoskeleton
and stress response process. This convinces us that peri-
odontally affected MSCs are a valid autologous MSC
source and that they could be employed for in vivo ap-
plications in diseases with a persistent inflammatory en-
vironment that generally harms the features and hinders
the success of cell transplantation. From a clinical point
of view, these findings are promising for future tissue
engineering applications in vivo.
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